BiologicsExtremitiesHospitalsNeuroReconSpineTop Stories

MedTechIntel user base has grown 54% year to date and no signs of slowing

Companies are needing to be more creative in how they reach their customers, and MedTechIntel has been providing the data for their users to be able to reach their specific market. Since coming out of their beta launch in January, customers are flocking to MTI’s premium data with a 54% increase in user activations.

MTI was birthed out of a major problem with the current data options out there. Other platforms did not consider relationships, CRM platforms were being self-populated, and data platforms required data scientists. Many of these companies do not have the resources to keep the data fresh.  The solution that MTI offers its users is that it does illustrate the relationships, the data is auto populated and updated regularly, and the team is staffed with an in-house data team for any customers data needs.

How MTI Compares to Other Technologies

“At the end of the day we want our customers to know that MTI is a relational roadmap and used as a sales management tool that we are constantly updating and making personalized to the user’s experience.” – Josh Sandberg , MTI CEO

The MTI data platform has 46,000 surgeon profiles, 6,000 sales profiles, 7,900 hospital profiles and 11,000 ASC profiles.  With many features being added weekly, this is a tool that ortho, spine and biologics manufacturers and distributors should have access to in order to make their job more efficient.

To learn more about MedTechIntel visit their site at: https://medtechintel.com/


Print Friendly, PDF & Email
Tags

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button
Close